News Headlines Article

For Big Drug Companies, a Headache Looms
New York Times

It would seem a business executive’s dream: legally pay a competitor to keep its product off the market for years. Congress has failed to stop it, and for more than a decade generic drug makers and big-name pharmaceutical companies have been winning court rulings that allowed it. Until this month. On July 16, a federal appeals court in Philadelphia issued a decision that the arrangement is anticompetitive on its face.

Commands